How Investors Are Reacting To Rubrik (RBRK) CrowdStrike Partnership

Simply Wall St · 1d ago
  • Rubrik held its Rubrik Healthcare Summit 2026 on 30 September 2026, where management outlined the shift from pure data protection toward broader identity security and AI-agent protection, alongside its existing data security platform.
  • A key message from the summit was how the alliance with CrowdStrike is intended to knit Rubrik's data protection with real-time threat detection, with the goal of making the platform a central security layer for healthcare and other enterprise clients despite ongoing pressure on profitability.
  • We will now look at how Rubrik's CrowdStrike collaboration and identity security push could influence the broader investment narrative.
Spot emerging security leaders that are riding the same identity and AI tailwinds as Rubrik by scanning our 36 profitable AI stocks that aren't just burning cash.

Rubrik Investment Narrative Recap

To own Rubrik, you need to believe its push beyond backup into identity security and AI driven protection can justify heavy investment while the business remains loss making. The near term swing factor is whether customers adopt this broader platform fast enough to support revenue forecasts while management keeps a grip on cash generation.

The sharpest risk is that cyber resilience rivals, from legacy vendors to new cloud based players, win those same identity and AI budgets, which could slow Rubrik's progress and keep profitability distant. The Healthcare Summit does not materially change that trade off. However, it underlines where execution now has to deliver.

The CrowdStrike alliance discussed at the Rubrik Healthcare Summit is the clearest recent signal of where operations are heading. Tying Rubrik Security Cloud to CrowdStrike's threat detection aims to make recovery decisions more data aware and quicker, especially for hospitals that cannot afford long outages or incomplete restorations.

For you as an investor, the collaboration sits right on top of the current catalysts and risks. It leans into Rubrik's identity recovery and AI agent ambitions, which could support revenue growth forecasts if customers standardise on this combined stack. It also raises the execution bar, because any integration issues or slow customer uptake would feed straight back into the profitability and valuation debate.

Rubrik's narrative projects US$2.7b revenue and US$308.7 million earnings by 2029. This assumes 20.0% yearly revenue growth and an earnings swing of about US$563 million from a loss of US$254.4 million today.

Uncover why Rubrik's fair value indicates a 4% potential downside to its current price, which leaves little room for error.

NYSE:RBRK 1-Year Stock Price Chart
NYSE:RBRK 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic analysts lean hard into Rubrik's identity and AI angle, arguing that tighter cyber insurance rules and AI agent oversight could justify faster scaling than the consensus view. They were already modeling 22.5% annual revenue growth and about US$332.7 million in 2029 earnings, so the Healthcare Summit may push those assumptions in new directions.

Explore 5 other Rubrik fair value estimates, including one that suggests it could be worth as much as $130.66.

Decide For Yourself

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Ideas Beyond Rubrik?

If the Rubrik story has you thinking about where else identity, security, and dependable cash flows could matter, it can help to scan a wider field of companies using the Simply Wall St Screener.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.